These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 30042175)

  • 1. R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.
    Lin TP; Li J; Li Q; Li X; Liu C; Zeng N; Huang JM; Chu GC; Lin CH; Zhau HE; Chung LWK; Wu BJ; Shih JC
    Mol Cancer Res; 2018 Dec; 16(12):1940-1951. PubMed ID: 30042175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HUWE1 upregulation has tumor suppressive effect in human prostate cancer cell lines through c-Myc.
    Qu H; Liu H; Jin Y; Cui Z; Han G
    Biomed Pharmacother; 2018 Oct; 106():309-315. PubMed ID: 29966975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of c-Myc expression by the histone demethylase JMJD1A is essential for prostate cancer cell growth and survival.
    Fan L; Peng G; Sahgal N; Fazli L; Gleave M; Zhang Y; Hussain A; Qi J
    Oncogene; 2016 May; 35(19):2441-52. PubMed ID: 26279298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
    Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
    Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The E3 ligase HUWE1 inhibition as a therapeutic strategy to target MYC in multiple myeloma.
    Crawford LJ; Campbell DC; Morgan JJ; Lawson MA; Down JM; Chauhan D; McAvera RM; Morris TC; Hamilton C; Krishnan A; Rajalingam K; Chantry AD; Irvine AE
    Oncogene; 2020 Jul; 39(27):5001-5014. PubMed ID: 32523091
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Umbreen S; Banday MM; Jamroze A; Mansini AP; Ganaie AA; Ferrari MG; Maqbool R; Beigh FH; Murugan P; Morrissey C; Corey E; Konety BR; Saleem M
    Mol Cancer Ther; 2019 Nov; 18(11):2111-2123. PubMed ID: 31467179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity.
    Kim J; Roh M; Abdulkadir SA
    BMC Cancer; 2010 Jun; 10():248. PubMed ID: 20515470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ubiquitin ligase CHIP regulates c-Myc stability and transcriptional activity.
    Paul I; Ahmed SF; Bhowmik A; Deb S; Ghosh MK
    Oncogene; 2013 Mar; 32(10):1284-95. PubMed ID: 22543587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of Circular RNA Itchy E3 Ubiquitin Protein Ligase Inhibits Cell Proliferation and Promotes Cell Apoptosis Through Targeting MiR-197 in Prostate Cancer.
    Yuan Y; Chen X; Huang E
    Technol Cancer Res Treat; 2019; 18():1533033819886867. PubMed ID: 31694481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guttiferone K impedes cell cycle re-entry of quiescent prostate cancer cells via stabilization of FBXW7 and subsequent c-MYC degradation.
    Xi Z; Yao M; Li Y; Xie C; Holst J; Liu T; Cai S; Lao Y; Tan H; Xu HX; Dong Q
    Cell Death Dis; 2016 Jun; 7(6):e2252. PubMed ID: 27253416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
    Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
    Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Derangements in HUWE1/c-MYC pathway confer sensitivity to the BET bromodomain inhibitor GS-626510 in uterine cervical carcinoma.
    Bonazzoli E; Bellone S; Zammataro L; Gnutti B; Guglielmi A; Pelligra S; Nagarkatti N; Manara P; Tymon-Rosario J; Zeybek B; Altwerger G; Menderes G; Han C; Ratner E; Silasi DA; Huang GS; Andikyan V; Azodi M; Schwartz PE; Santin AD
    Gynecol Oncol; 2020 Sep; 158(3):769-775. PubMed ID: 32600791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of BRD4 suppresses tumor growth in prostate cancer via the enhancement of FOXO1 expression.
    Tan Y; Wang L; Du Y; Liu X; Chen Z; Weng X; Guo J; Chen H; Wang M; Wang X
    Int J Oncol; 2018 Dec; 53(6):2503-2517. PubMed ID: 30272279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 inhibits prostate cancer by destabilizing oncoprotein c-MYC through regulation of the PI3K/Akt pathway.
    Quan Y; Wang N; Chen Q; Xu J; Cheng W; Di M; Xia W; Gao WQ
    Oncotarget; 2015 Sep; 6(28):26494-507. PubMed ID: 26317998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
    Lu W; Yang C; He H; Liu H
    Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription factor FoxM1 is the downstream target of c-Myc and contributes to the development of prostate cancer.
    Pan H; Zhu Y; Wei W; Shao S; Rui X
    World J Surg Oncol; 2018 Mar; 16(1):59. PubMed ID: 29554906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of ARF-BP1/HUWE1 interactions with CTCF, MYC, ARF and p53 in MYC-driven B cell neoplasms.
    Qi CF; Kim YS; Xiang S; Abdullaev Z; Torrey TA; Janz S; Kovalchuk AL; Sun J; Chen D; Cho WC; Gu W; Morse Iii HC
    Int J Mol Sci; 2012; 13(5):6204-6219. PubMed ID: 22754359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MULE/HUWE1 E3 ubiquitin ligase is a tumor suppressor.
    Cancer Discov; 2013 Jul; 3(7):OF32. PubMed ID: 23847377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression.
    Yuan Y; Wang LH; Zhao XX; Wang J; Zhang MS; Ma QH; Wei S; Yan ZX; Cheng Y; Chen XQ; Zou HB; Ge J; Wang Y; Zhang X; Cui YH; Luo T; Bian XW
    Cancer Commun (Lond); 2022 Sep; 42(9):868-886. PubMed ID: 35848447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.